Skip to search formSkip to main contentSkip to account menu

icariside II

Known as: icarisid II 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Chronic cerebral hypoperfusion (CCH) is a basic pathological process that is comorbid with brain diseases, such as vascular… 
2017
2017
Icarisid II, one of the main active components of Herba Epimedii extracts, shows potent antitumor activity in various cancer cell… 
2017
2017
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor, and currently chemotherapeutic options for GBM… 
2016
2016
The potential effect of icariside II on dexamethasone-induced osteoblast cell damages was evaluated here. In MC3T3-E1… 
2016
2016
The aberrant energy homeostasis that characterized by high rate of energy production (glycolysis) and energy consumption (mRNA… 
2015
2015
The biggest challenge for the treatment of multidrug resistant cancer is to deliver a high concentration of anticancer drugs to… 
2012
2012
In the present study, an icariside II-phospholipid complex was prepared, and its physicochemical properties including UV spectrum… 
2008
2008
An LC-MS-MS method was revised and validated for simultaneous determination of icariin and its active metabolite icariside II in…